Reshma Rangwala
CIK 1825322 · EVP & Chief Medical Officer · last filed 2026-05-15
Reshma Rangwala is an EVP & Chief Medical Officer who has filed 18 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for KPTI, was dated May 15, 2026. Across all open-market trades the lifetime net is −$144.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $539.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$539.9K
2
18
-$144.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KPTI | EVP & Chief Medical Officer | 56,829 | $9.50 | $539.9K | -$144.2K | 15 | 2026-05-15 |
| Aravive, Inc. (ARAV) Delisted | Chief Medical Officer | — | $0.04 | — | $0 | 3 | 2022-01-25 |
Recent Filings
18 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-15 | KPTI | Mixed | +539 | -$3.9K | EDGAR |
| 2026-04-22 | KPTI | Sell (S) | −449 | -$4.0K | EDGAR |
| 2026-03-03 | KPTI | Sell (S) | −5,066 | -$47.7K | EDGAR |
| 2026-02-03 | KPTI | Grant (A) | +32,415 | $0 | EDGAR |
| 2025-09-16 | KPTI | Mixed | +537 | -$2.6K | EDGAR |
| 2025-04-24 | KPTI | Sell (S) | −419 | -$2.6K | EDGAR |
| 2025-03-06 | KPTI | Sell (S) | −3,587 | -$22.6K | EDGAR |
| 2025-03-04 | KPTI | Grant (A) | +9,999 | $0 | EDGAR |
| 2024-04-23 | KPTI | Sell (S) | −6,789 | -$7.9K | EDGAR |
| 2024-03-04 | KPTI | Sell (S) | −21,636 | -$25.5K | EDGAR |